Cargando…

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study

BACKGROUND: Concerns have been raised that HPV-vaccination might affect women’s cervical screening behavior. We therefore investigated the association between opportunistic HPV-vaccination and attendance after invitation to cervical screening. METHODS: A cohort of all women resident in Sweden, born...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herweijer, Eva, Feldman, Adina L., Ploner, Alexander, Arnheim-Dahlström, Lisen, Uhnoo, Ingrid, Netterlid, Eva, Dillner, Joakim, Sparén, Pär, Sundström, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517931/ https://www.ncbi.nlm.nih.gov/pubmed/26218492 http://dx.doi.org/10.1371/journal.pone.0134185

Ejemplares similares

Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study
por: Herweijer, Eva, et al.
Publicado: (2016)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study
por: F, Lamb, et al.
Publicado: (2017)

Assessing Perceived Risk and STI Prevention Behavior: A National Population-Based Study with Special Reference to HPV
por: Leval, Amy, et al.
Publicado: (2011)

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
por: Wang, Jiangrong, et al.
Publicado: (2016)

Sexually transmitted infections after bereavement – a population-based cohort study
por: Bond, Emily, et al.
Publicado: (2016)

Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden
por: Rehn, Moa, et al.
Publicado: (2016)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Incidence of herpes zoster and associated events including stroke—a population-based cohort study
por: Sundström, Karin, et al.
Publicado: (2015)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2012)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2013)

Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
por: Kreusch, Teresa, et al.
Publicado: (2018)

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016)

Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders
por: Herweijer, Eva, et al.
Publicado: (2023)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019
por: Wang, Jiangrong, et al.
Publicado: (2023)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
por: Andrae, Bengt, et al.
Publicado: (2019)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2021)

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study
por: Smelov, Vitaly, et al.
Publicado: (2016)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Screening and cervical cancer cure: population based cohort study
por: Andrae, Bengt, et al.
Publicado: (2012)

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
por: Fogelberg, Sara, et al.
Publicado: (2020)

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
por: Barrett, James E., et al.
Publicado: (2022)

Patients’ perspectives on the effect of the COVID-19 pandemic on access to cancer care and social contacts in Sweden and the UK: a cross-sectional study
por: Edlund, Karolina, et al.
Publicado: (2022)

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
por: Lehtinen, Matti, et al.
Publicado: (2022)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
por: Arbyn, Marc, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sg62v3glc8sqp16mhlrts1nadq